Table 2.
Distribution of post-partum blood loss (mL) by receipt of AMTSL components (N = 39184)*
| n | Mean total blood loss (SD) | Median total blood loss (IQR) | Range | |
|---|---|---|---|---|
|
No oxytocin prophylaxis |
||||
| No AMTSL components |
1832 |
325 (240) |
250 (200) |
50-1800 |
| UM only |
959 |
368 (268) |
300 (250) |
50-2000 |
| CCT only |
4014 |
181 (167) |
135 (95) |
10-1550 |
| CCT + UM |
1416 |
247 (255) |
145 (125) |
25-1350 |
|
Oxytocin prophylaxis |
||||
| Intramuscular administration |
||||
| Oxytocin only |
2853 |
335 (234) |
300 (200) |
25-3000 |
| Oxytocin + CCT |
6103 |
279 (115) |
300 (100) |
100-2500 |
| Oxytocin + CCT + UM |
4085 |
240 (195) |
200 (180) |
0-2250 |
| Intravenous administration |
||||
| Oxytocin only |
785 |
277 (175) |
250 (200) |
50-2000 |
| Oxytocin + CCT |
794 |
272 (149) |
250 (120) |
50-1700 |
| Oxytocin + CCT + UM | 16343 | 235 (152) | 200 (100) | 30-2000 |
*Total blood loss was recorded upon cessation of active bleeding.
AMTSL denotes active management of the third stage of labor; CCT, controlled cord traction; UM, uterine massage; SD, standard deviation; and IQR, inter-quartile range.